Table 1.
Distribution of disease severity, anti-ACE2 autoantibody and CR antibody positive rate in COVID-19 patients with vaccination (Vac) or without (UnVac)
| Demographic | UnVac (n = 31) | Vac (n = 89) | P valuea |
|---|---|---|---|
| Disease severity | < 0.0001 | ||
| Mild | 4 (12.9%) | 63 (70.8%) | |
| Positive for Anti-ACE2 autoAb | 1 (25%) | 7 (11.1%) | ns |
| Positive for CR Ab | 0 | 1 (1.6%) | ns |
| Moderate/Severe | 27 (87.1%) | 26 (29.2%) | |
| Positive for Anti-ACE2 autoAb | 18 (66.7%) | 7 (26.9%) | 0.058 |
| Positive for CR Ab | 9 (33.3%) | 1 (3.8%) | 0.011 |
Abbreviation: ns not significant
aThe Fisher exact test was used to determine the P values